25-000064 BD bioscience instrument rental and reagent package
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N90025D00006
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- BD Biosciences Proprietary Instrumentation Package and Reagent Kits Pre-Solicitation · NIHCCOPC25000064 · Posted Oct 31, 2024
- Last date to order 90% complete
- IDV ceiling
- $1,250,000.00
- Maximum order
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health Clinical Center has awarded a single-award Indefinite Delivery Contract valued at $1.25 million to Becton, Dickinson and Company's BD Biosciences division for BD instrumentation packages, reagent kits, quality control materials, and supplies supporting the Hematology Flow Cytometry Service. The contract was awarded on January 1, 2025, with an ultimate completion date of December 31, 2026, and includes optional extensions through 2029. This sole-source acquisition was conducted under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures without competitive re-solicitation requirements, as the specified proprietary reagent kits are exclusively compatible with the BD Rhapsody single-cell analysis system currently deployed at the NIH Clinical Center. No small business set-aside was applied to this procurement. The contract authorizes the issuance of subsequent task and delivery orders for option years one through four, enabling streamlined procurement of specialized instrumentation and consumables essential to patient care and biomedical research testing operations.
The acquisition procures BD Rhapsody single-cell analysis reagent kits, flow cytometry system components, quality control materials, and associated laboratory supplies necessary for hematology research and clinical diagnostics at the NIH Clinical Center. As the sole manufacturer and trademark holder of the specified proprietary reagent kits, Becton, Dickinson and Company possesses exclusive capability to fulfill this requirement. The contract's indefinite delivery structure provides the federal agency with flexible, efficient access to critical biomedical instrumentation and consumables without requiring competitive re-solicitation for individual task orders, thereby supporting continuous operational capacity for the Clinical Center's hematology flow cytometry laboratory services throughout the contract period extending through 2026 with optional extensions.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $250,000 |
Quick answers
Who was awarded contract 75N90025D00006?
75N90025D00006 was awarded to Becton, Dickinson And Company by NIH Clinical Center (National Institutes of Health) on January 1, 2025.
How much is contract 75N90025D00006 worth?
75N90025D00006's own ceiling is $1,250,000. A single order can be worth up to $250,000.
Who can order from contract 75N90025D00006?
75N90025D00006 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N90025D00006 competed?
The extent of competition for 75N90025D00006 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV